Third Point Ventures Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 4
- Investments
- 102
- Portfolio
- 30
- Exits
- 47
Third Point Ventures General Information
Description
Founded in 2000, Third Point Ventures is the investment arm of Third Point LLC based in Menlo Park, California. The firm seeks to invest in the early stage and provide growth capital, cross-over investments to the companies focusing on enterprise, fintech, mobile, and healthcare technology sectors.
Contact Information
Website
www.thirdpointventures.com
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 2180 Sand Hill Road
- Suite 210
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
Third Point Ventures Investments (102)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Rivian | 23-Jul-2021 | Later Stage VC | 00.00 | Automotive | Generating Revenue | |
| 000000 00000000000 | 15-Jul-2021 | 00000 00000 | 00000 | Multimedia and Design Software | Generating Revenue | |
| 00000000000 | 30-May-2021 | 00000 00000 | 000.00 | Financial Software | Generating Revenue | 000000 00000000 |
| 000000 | 25-May-2021 | 00000 00000 | 00000 | Business/Productivity Software | Generating Revenue | |
| 00000000000 | 07-May-2021 | 00000 00000 | 00000 | Computers, Parts and Peripherals | Generating Revenue | |
| 000000 | 19-Apr-2021 | 00000 00000 | 00000 | Business/Productivity Software | Generating Revenue | 000000 00000000 |
| 0000 00000 | 13-Apr-2021 | 00000 00000 | 000 | Entertainment Software | Generating Revenue | |
| 000000000 | 01-Apr-2021 | 00000 00000 | 0000 | Business/Productivity Software | Generating Revenue | 000 000000000 |
| Ventyx Biosciences | 09-Mar-2021 | Early Stage VC | 00000 | Drug Discovery | Clinical Trials - General | 00000 0000000 |
| Ushur | 09-Feb-2021 | Later Stage VC | 0000 | Business/Productivity Software | Generating Revenue | 000000 00000000 |
Third Point Ventures Exits (47)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Didi Global | 30-Jun-2021 | IPO | 00.000 |
| 00000000000 | 30-Jun-2021 | 000 | 00.000 |
| 0000 | 28-May-2021 | 0000000 000000 | 00.00 |
| 0000000 (000000000 | 12-Apr-2021 | 000000 0000000000 | 00000 |
| 0000000 0000 | 04-Jan-2021 | 000 00 00000000 | |
| 0000000 (000000000 | 16-Dec-2020 | 000 | 00000 |
| 0000 | 16-Dec-2020 | 000 | 00.00 |
| 00000000 000000000 | 30-Sep-2020 | 000 | 00.000 |
| Packet | 02-Mar-2020 | Merger/Acquisition | 00000 |
| Rodin Therapeutics | 25-Nov-2019 | Merger/Acquisition | 00000 |
Third Point Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialThird Point Ventures Team (8)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Robert Schwartz | Managing Partner | 00 | 0 | 00 | Menlo Park, CA |
| Curtis McKee | Partner | Menlo Park, CA | |||
| Dan Moskowitz | Principal | 0 | 0 | 0 | Menlo Park, CA |
| Daniel Loeb | Founder & Chief Executive Officer | 00 | 0 | 0 | Menlo Park, CA |
| Jigar Choksey | Principal | 0 | 0 | 0 | Menlo Park, CA |
Third Point Ventures Co-Investors (173)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Accel | 3 | 0 |
|
|
|
| Samsung Venture Investment | 0 | 0 |
|
|
|
| Aperture Venture Partners | 0 | 0 | 0 |
|
|
| Bessemer Venture Partners | 0 | 0 | 0 |
|
|
| Insight Partners | 0 | 0 |
|
|